Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer
Clinical trial NCT02525237 · UNKNOWN
Trial details
- NCT number
- NCT02525237
- Sponsor
- Qingdao Municipal Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.